The FDA has expanded the indications for Insulet SmartAdjust technology to include the management of Type 2 diabetes in people 18 and older. Insulet SmartAdjust is an interoperable, automated glycemic ...
The FDA cleared the first automated insulin dosing device for adults with type 2 diabetes, the agency announced on Monday. An interoperable automated glycemic controller, Insulet's SmartAdjust ...
ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced ...
“The addition of the Abbott FreeStyle Libre 2 Plus sensor to our CGM compatibility expands accessibility of Omnipod 5, which has been a priority for Insulet since the system launched in 2022,” said ...
SILVER SPRING, Md., Aug. 26, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration expanded the indications of the Insulet SmartAdjust technology, an interoperable automated glycemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results